Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HICKEY, Anthony J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 60

  • Page / 3
Export

Selection :

  • and

PLGA Microparticles in Respirable Sizes Enhance an In Vitro T Cell Response to Recombinant Mycobacterium Tuberculosis Antigen TB10.4-Ag85BSHUAI SHI; HICKEY, Anthony J.Pharmaceutical research. 2010, Vol 27, Num 2, pp 350-360, issn 0724-8741, 11 p.Article

Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis : Manufacture and characterizationO'HARA, Patrick; HICKEY, Anthony J.Pharmaceutical research. 2000, Vol 17, Num 8, pp 955-961, issn 0724-8741Article

Isoxyl particles for pulmonary delivery: In vitro cytotoxicity and potencyCHENCHEN WANG; HICKEY, Anthony J.International journal of pharmaceutics (Print). 2010, Vol 396, Num 1-2, pp 99-104, issn 0378-5173, 6 p.Article

Particle Interactions in Dry Powder Inhaler Unit Processes: A ReviewZHEN XU; MANSOUR, Heidi M; HICKEY, Anthony J et al.Journal of adhesion science and technology. 2011, Vol 25, Num 4-5, pp 451-482, issn 0169-4243, 32 p.Article

Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Alternative Sugar Blends: 3. Trehalose Dihydrate and D-Mannitol CarriersMANSOUR, Heidi M; ZHEN XU; HICKEY, Anthony J et al.Journal of pharmaceutical sciences. 2010, Vol 99, Num 8, pp 3430-3441, issn 0022-3549, 12 p.Article

Manufacture, characterization, and pharmacodynamic evaluation of engineered ipratropium bromide particlesTAYLOR, Michael K; HICKEY, Anthony J; VANOORT, Michiel et al.Pharmaceutical development and technology. 2006, Vol 11, Num 3, pp 321-336, issn 1083-7450, 16 p.Article

Immunological and toxicological implications of short-term studies in animals of pharmaceutical aerosol delivery to the lungs : Relevance to humansHICKEY, Anthony J; GARCIA-CONTRERAS, Lucila.Critical reviews in therapeutic drug carrier systems. 2001, Vol 18, Num 4, pp 387-431, issn 0743-4863Article

Dry Powder Nasal Vaccines as an Alternative to Needle-Based DeliveryGARMISE, Robert J; HICKEY, Anthony J.Critical reviews in therapeutic drug carrier systems. 2009, Vol 26, Num 1, pp 1-27, issn 0743-4863, 27 p.Article

Calibration of the Andersen Cascade Impactor for the Characterization of Nasal ProductsGARMISE, Robert J; HICKEY, Anthony J.Journal of pharmaceutical sciences. 2008, Vol 97, Num 8, pp 3462-3466, issn 0022-3549, 5 p.Article

Investigation of triboelectric charging in dry powder inhalers using electrical low pressure impactor (ELPI™)TELKO, Martin J; KUJANPHFI, Jukka; HICKEY, Anthony J et al.International journal of pharmaceutics. 2007, Vol 336, Num 2, pp 352-360, issn 0378-5173, 9 p.Article

Aerosol treatment of cystic fibrosisGARCIA-CONTRERAS, Lucila; HICKEY, Anthony J.Critical reviews in therapeutic drug carrier systems. 2003, Vol 20, Num 5, pp 317-356, issn 0743-4863, 40 p.Article

Particle-size analysis of pharmaceutical aerosolsHICKEY, Anthony J; JONES, Latarsha D.Pharmaceutical technology. 2000, Vol 24, Num 9, pp 48-58, issn 0147-8087, 6 p.Article

Inhaled Drug Delivery for Tuberculosis TherapyMUTTIL, Pavan; CHENCHEN WANG; HICKEY, Anthony J et al.Pharmaceutical research. 2009, Vol 26, Num 11, pp 2401-2416, issn 0724-8741, 16 p.Article

Critical assessment of inverse gas chromatography as means of assessing surface free energy and acid-base interaction of pharmaceutical powdersTELKO, Martin J; HICKEY, Anthony J.Journal of pharmaceutical sciences. 2007, Vol 96, Num 10, pp 2647-2654, issn 0022-3549, 8 p.Article

Pharmaceutical powdersHICKEY, Anthony J; SWIFT, David L.Particulate science and technology. 1997, Vol 15, Num 3, issn 0272-6351, 81 p.Serial Issue

Isoxyl assays in plasmaCHENCHEN WANG; GARCIA-CONTRERAS, Lucila; MUTTIL, Pavan et al.Journal of pharmaceutical and biomedical analysis. 2012, Vol 60, pp 1-6, issn 0731-7085, 6 p.Article

Standardized entrainment tubes for the evaluation of pharmaceutical dry powder dispersionLOUEY, Margaret D; VAN OORT, Michiel; HICKEY, Anthony J et al.Journal of aerosol science. 2006, Vol 37, Num 11, pp 1520-1531, issn 0021-8502, 12 p.Article

Thermal limits of portunid crab heart mitochondria: Could more thermo-stable mitochondria advantage invasive species?IFTIKAR, Fathima I; MACDONALD, Julia; HICKEY, Anthony J. R et al.Journal of experimental marine biology and ecology. 2010, Vol 395, Num 1-2, pp 232-239, issn 0022-0981, 8 p.Article

Atomization mechanisms of the pressurized metered dose inhalerDUNBAR, C. A.Particulate science and technology. 1997, Vol 15, Num 3, pp 195-216, issn 0272-6351Article

Dry Powder Vaccines for Mucosal Administration: Critical Factors in Manufacture and DeliveryWANG, Sheena H; THOMPSON, Afton L; HICKEY, Anthony J et al.Current Topics in Microbiology and Immunology. 2012, Vol 354, pp 121-156, issn 0070-217X, 36 p.Article

Rational Design of Multiple TB Antigens TB10.4 and TB10.4-Ag85B as Subunit Vaccine Candidates Against Mycobacterium TuberculosisSHUAI SHI; LAN YU; DENGYUN SUN et al.Pharmaceutical research. 2010, Vol 27, Num 2, pp 224-234, issn 0724-8741, 11 p.Article

Immediate and short-term cellular and biochemical responses to pulmonary single-dose studies of insulin and H-MAPGARCIA-CONTRERAS, Lucila; SARUBBI, Donald; FLANDERS, Elizabeth et al.Pharmaceutical research. 2001, Vol 18, Num 12, pp 1685-1693, issn 0724-8741Article

Phase I, Single-Dose, Dose-Escalating Study of Inhaled Dry Powder Capreomycin: a New Approach to Therapy of Drug-Resistant TuberculosisDHARMADHIKARI, Ashwin S; KABADI, Mohan; GERETY, Bob et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 6, pp 2613-2619, issn 0066-4804, 7 p.Article

Pharmacokinetics of Sequential Doses of Capreomycin Powder for Inhalation in Guinea PigsGARCIA-CONTRERAS, L; MUTTIL, Pavan; FALLON, John K et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 5, pp 2612-2618, issn 0066-4804, 7 p.Article

Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemiaHICKEY, Anthony J; HAZLETT, Karsten R. O; KIRIMANJESWARA, Girish S et al.Vaccine. 2011, Vol 29, Num 40, pp 6941-6947, issn 0264-410X, 7 p.Article

  • Page / 3